Apalutamide Makes Its Case in Biochemically Recurrent Nonmetastatic Prostate Cancer

Intensification should be considered for high-risk patients, researchers say

Related Keywords

Mayo Clinic In Rochester ,Minnesota ,United States ,Massachusetts ,Daniel Childs ,Rahul Aggarwal ,Mike Bassett ,University Of California San Francisco ,California San Francisco ,Clinical Oncology ,Mayo Clinic ,Clin Oncol ,